Differentiating poorly differentiated prostatic carcinoma and high grade urothelial carcinoma by immunohistochemistry

Histopathologic and immunohistochemical study ofexpression of WAF 1 P21 oncoprotein in benign,premalignant and prostatic carcinoma

Immunohistochemical expression of cyclooxygenaSe-2 (Cox-2) in benign prostatic hyperplasia and prostatic adenocarcinoma

Morphometric and DNA ploidy study of benign, precancerous and malignant prostatic lesions

Role of Immunohistochemistry in the Differentiation between Low Grade Prostatic Adenocarcinoma (Small Acinar Pattern) and Some Benign Mimickers

Experession of the C-erb B-2 (HER-2/neu) oncoprotein in some benign and malignant prostatic lesions

Diagnostic utility of alpha- methylacyl–CoAracemase (AMACR) and p63 in high-gradeprostatic intraepithelial neoplasia (PIN) andprostatic adenocarcinoma

Cyclin D1 expression in prostatic carcinoma

The role of complexed prostate-specific antigen in the detection of prostatic carcinoma

Immunohistochemical study of stromal CD 10 expression in mammary duct carcinoma